Literature DB >> 1963076

Multiple defects of the nerve growth factor receptor in human neuroblastomas.

C G Azar1, N J Scavarda, C P Reynolds, G M Brodeur.   

Abstract

Neuroblastoma is a tumor of postganglionic sympathetic origin, and nerve growth factor (NGF) is normally required for the survival and differentiation of sympathetic neuroblasts. Since the biological activity of NGF is mediated by the NGF receptor (NGFR), we hypothesized that defects in the NGF/NGFR pathway may play a role in maintenance of the undifferentiated state of neuroblastomas. To test this hypothesis, we examined the structure of the NGFR at the DNA, RNA, and protein levels in a panel of 10 neuroblastoma cell lines. In addition, we examined the function of the NGFR in these lines by analysis of NGF binding kinetics, as well as by the ability of NGF to induce c-fos expression and neurite outgrowth. Southern blot analysis showed that all 10 cell lines possess apparently normal NGFR genes. Northern blot and ligand binding/immunoprecipitation assays revealed four receptor-positive cell lines (NGP, NLF, SK-N-SH, and LA-N-6), with NGFR mRNA and protein of expected sizes (3.8 kilobases and Mr approximately 75,000, respectively). NGF binding assays and Scatchard analyses were performed on the four NGFR-positive lines. The NGP line possesses only low-affinity receptor (Kd approximately 3.5 x 10(-9)), whereas the other three lines express both low- and high-affinity forms (Kd approximately 10(-9) and Kd approximately 10(-11), respectively). However, none of the 10 lines exhibited a response to NGF treatment as assayed by c-fos mRNA induction and neurite extension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963076

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  17 in total

1.  Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.

Authors:  D L Baker; W M Molenaar; J Q Trojanowski; A E Evans; A H Ross; L B Rorke; R J Packer; V M Lee; D Pleasure
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

2.  Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma.

Authors:  C Dominici; M R Nicotra; S Alemà; C Bosman; M A Castello; A Donfrancesco; P Gallo; H McDowell; P G Natali
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Expression of TrkA, TrkB and TrkC in human neuroblastomas.

Authors:  G M Brodeur; A Nakagawara; D J Yamashiro; N Ikegaki; X G Liu; C G Azar; C P Lee; A E Evans
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

4.  Tumor cell complementation groups based on myogenic potential: evidence for inactivation of loci required for basic helix-loop-helix protein activity.

Authors:  A N Gerber; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  The reverse transforming effects of nerve growth factor on five human neurogenic tumor cell lines: in vitro results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.

Authors:  C J Kim; T Matsuo; K H Lee; C J Thiele
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Insulin-like growth factor-I is a serum component stimulating growth of human neuroblastoma.

Authors:  T W Burke; S Vuk-Pavlović
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

9.  Expression and function of TRK-B and BDNF in human neuroblastomas.

Authors:  A Nakagawara; C G Azar; N J Scavarda; G M Brodeur
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo.

Authors:  H Matsushima; E Bogenmann
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.